Daniel George Wildman

Insider Reports History

Location
Wellington, FL
Signature
/s/ Jason D. Smith, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel George Wildman:

Company Role Class Num Shares Value Price $ Report Date Ownership
UroGen Pharma Ltd. Director ordinary shares 2,000 $39,560 $19.78 26 Nov 2025 Direct
UroGen Pharma Ltd. Director Stock Option (right ot buy) 10,000 26 Aug 2025 Direct
UroGen Pharma Ltd. Director Restricted Stock Unit 6,000 26 Nov 2025 Direct

Insider Reports Filed by Daniel George Wildman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
URGN UroGen Pharma Ltd. 26 Nov 2025 2 $0 4 Director 01 Dec 2025, 16:44
URGN UroGen Pharma Ltd. 26 Aug 2025 2 $0 4 Director 27 Aug 2025, 16:39
URGN UroGen Pharma Ltd. 06 Aug 2024 1 $0 4 Director 08 Aug 2024, 09:10
URGN UroGen Pharma Ltd. 07 Sep 2023 1 $0 4 Director 08 Sep 2023, 15:42
URGN UroGen Pharma Ltd. 08 Nov 2022 0 $0 3 Director 09 Nov 2022, 16:57
URGN UroGen Pharma Ltd. 08 Nov 2022 1 $0 4 Director 09 Nov 2022, 16:57